The human MHC 1 class I genes encode the highly polymorphic HLA class I antigen heavy chains, membrane-spanning proteins that combine with the invariant  2 -microglobulin to form the HLA class I surface antigen (1). Classical MHC class I (HLA-A, -B, and -C) antigen expression is essential for processing and presentation of peptide antigens to cytotoxic CD8ϩ lymphocytes (2). In addition, recent evidence suggests that certain classical and nonclassical class I antigens play an important role in inhibition of natural killer (NK) cell function (3-6) and certain subsets of cytotoxic T-cells (7). Therefore, changes in MHC class I gene expression can have profound effects on the overall susceptibility to NK cell and cytotoxic T-cell-mediated lysis, the net effect depending on the specific MHC Class I genes involved. Down-regulation of MHC class I gene expression is observed in many human tumors and transformed cell lines, resulting in decreased susceptibility to cytotoxic T-cell-mediated lysis (8 -13). Global down-regulation of surface class I expression can arise by several mechanisms, including loss of  2 -microglobulin or peptide transporter gene expression (9, 14). More frequently, loss of MHC class I antigen expression in tumor cells occurs at a single locus. For example, selective down-regulation of HLA-B locus gene expression has been observed in many cell lines derived from patients with metastatic melanoma (15) and colon cancer (16). The specific MHC class I alleles in a particular tumor that activate cytotoxic T-cells may be different from those that inhibit NK cell function. Therefore, understanding how MHC class I antigen expression is controlled at the level of specific loci and alleles is an important goal with possible implications for the development of vaccine-based cancer therapeutics.The mechanisms that mediate locus-specific down-regulation of MHC class I gene expression are incompletely understood. Transcriptional mechanisms appear to be involved in many cases (17-19) but have not been well characterized. The promoter and 5Ј-flanking regions of most MHC class I genes contain several highly conserved, well characterized DNA sequence elements involved in maintenance of constitutive expression (20 -22). Down-regulation of MHC class I expression due to decreased binding of members of the rel family of transcription factors to the highly conserved enhancer A element has been reported in human tumor cell lines (23) and in adenovirus-12-transformed cell lines (24). Our laboratory has previously shown that another highly conserved element, the interferon-stimulated response element, functions as a locusspecific activator of HLA-A gene expression in several